EMA and ECDC statement on updating COVID-19 vaccines to target new SARS-CoV-2 virus variants

EMA

6 June 2023 - The European Centre for Disease Prevention and Control and the European Medicines Agency have issued a joint statement on adapted COVID-19 vaccines and considerations for their use during the upcoming autumn 2023 vaccination campaigns.

Currently authorised vaccines continue to be effective at preventing hospitalisation, severe disease and death due to COVID-19. However, protection against the virus declines over time as new SARS-CoV-2 variants emerge.

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder